Sequentially conquering transfection obstacles of primary human T cells via non-classical lipid nanoparticles delivering reformative transposon system
- 28 April 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 383, 113779
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Province Natural Science Foundation (BK20212011)
- National Natural Science Foundation of China (82073785, 92159304, 81930099, 82130102)
- Double First Class University Plan (CPU2022QZ05)
- China Pharmaceutical University
- State Key Laboratory of Natural Medicines
- National Major Science and Technology Projects of China (2019ZX09301163)
This publication has 39 references indexed in Scilit:
- Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivoJournal of Controlled Release, 2022
- Non-viral transfection technologies for next-generation therapeutic T cell engineeringBiotechnology Advances, 2021
- DNA nuclear targeting sequences for enhanced non-viral gene transfer: An in vitro and in vivo studyMolecular Therapy Nucleic Acids, 2021
- Nonviral gene delivery to T cells with Lipofectamine LTXBiotechnology and Bioengineering, 2021
- Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting LigandsAdvanced Materials, 2019
- Brief update on endocytosis of nanomedicinesAdvanced Drug Delivery Reviews, 2019
- MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics TrajectoriesBiophysical Journal, 2015
- The proteoglycan repertoire of lymphoid cellsGlycoconjugate Journal, 2012
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011